Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10874338 | PMC |
| http://dx.doi.org/10.1007/s13760-023-02339-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Protocol for a randomized controlled trial of patient-portal-based screening for substance use among people with HIV.
Front Public Health
September 2025
Department of Medicine, University of Chicago, Chicago, IL, United States.
Background: Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life with HIV and Substance Use (ePORTAL HIV-S) is a research project funded by the National Institute for Drug Abuse to implement and evaluate multi-level interventions to decrease barriers to substance use screening and treatment for PLWH. At its center is a multidomain intervention addressing digital, sociocultural, and health care system environments, at individual, interpersonal, and community levels. ePORTAL HIV-S has four overall goals; this manuscript describes the protocol specifically for the randomized control trial (RCT) portion of the study.
View Article and Find Full Text PDFBackground: Overweight and obesity are major concerns among people living with HIV (PLWH), particularly those on integrase inhibitors, as they elevate the risk of cardiovascular diseases. However, longitudinal data on the burden and risk factors for overweight/obesity in sub-Saharan Africa (SSA) remain limited. This study aimed to estimate the incidence and identify factors associated with overweight and obesity among PLWH who switched to a dolutegravir (DTG)-based ART regimen at Livingstone University Teaching Hospital.
View Article and Find Full Text PDFHIV-Associated Lymphomas: Updates from Pathogenesis to Treatment Strategies.
Curr HIV Res
September 2025
Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.
HIV-associated lymphoma (HAL) is an aggressive malignancy directly linked to HIV infection and accounts for more than 30% of cancer-related deaths in people living with HIV (PLWH). HAL subtypes, including diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), primary effusion lymphoma (PEL), and plasmablastic lymphoma (PBL), exhibit five to ten times higher incidence rates and distinct molecular profiles compared to HIV-negative lympho-mas. Pathogenesis involves HIV-driven CD4+ T-cell depletion, chronic B-cell activation, and on-cogenic viral coinfection.
View Article and Find Full Text PDFFactors Contributing to Pneumococcal, COVID-19, and Influenza Vaccine Uptake Among People Living With HIV in Belgium: A Retrospective Study.
Open Forum Infect Dis
September 2025
Infectious Diseases Department, Liège University Hospital of Liège, Liège, Belgium.
Background: Despite antiretroviral therapy, people living with HIV (PLWH) remain vulnerable to vaccine-preventable diseases. Although vaccination is strongly recommended, data on vaccine uptake among PLWH in Belgium remain scarce. This study aims to assess pneumococcal, COVID-19, and influenza vaccine coverage in PLWH in Belgium and identify factors associated with vaccine uptake.
View Article and Find Full Text PDFDelayed CD4 cell recovery in HIV-associated disseminated non-tuberculous mycobacterial disease: a case-control study.
Int J Infect Dis
September 2025
Goethe-University Frankfurt, University Hospital, Department of Medicine no. 2, Infectious Diseases. Electronic address:
Objectives: Disseminated nontuberculous mycobacterial disease (dNTMd) remains a rare but serious complication in people living with HIV (PLWH). This study aimed to assess whether dNTMd independently contributes to delayed CD4-cell recovery following antiretroviral therapy (ART) initiation.
Methods: This retrospective 1:3 single center case-control study analyzed patient data from 2004 to 2023.